View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 8.0 Contact Hours.

Acknowledgment of Commercial Support

This educational activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Genmab US, Inc.; Incyte Corporation; Oncopeptides, Inc.; Pfizer Inc.; Sanofi Genzyme; and Seattle Genetics.

4th Annual Live Medical Crossfire®: Hematologic Malignancies

4th Annual Live Medical Crossfire®: Hematologic Malignancies

Saturday, July 11, 2020


4th Annual Live Medical Crossfire®: Hematologic Malignancies Overview

Physicians’ Education Resource®, LLC (PER®), presents the 4th Annual Live Medical Crossfire®: Hematologic Malignancies—a 1-day, highly engaging conference designed to explore the most pressing clinical issues in the field of hematologic malignancies through live, interactive panel discussions with renowned experts. This meeting will contrast viewpoints of key thought leaders from across the country and world regarding current standards of practice and emerging clinical data for liquid tumors. Through this valuable discussion, healthcare professionals participating in this conference will be better equipped to treat a broad range of patients with hematologic malignancies; more informed regarding current controversies and changing treatment paradigms in these tumor types; and will more confident in personalizing clinical decisions for their patients.

At the start of each Medical Crossfire® segment, renowned experts across the field of liquid tumors—from leukemias and lymphomas to myeloma—will present a brief, evidence-based assessment of current standards of practice and the most important clinical trial data, to set the stage for the ensuing crossfire segment. Each segment concludes with a crossfire from the live audience. This innovative format provides the most practical and engaging educational forum available today in the field of hematologic malignancies.

Benefits of Attending a Hematology/Oncology CME, Presented by PER®

  • Hear how the experts and your peers are treating their patients with hematologic malignancies, using examples from challenging, real-world cases
  • Determine optimal treatment algorithms for specific patient groups across hematologic malignancies
  • Improve your knowledge about how emerging and cutting-edge treatments may be incorporated into your clinical practice
  • Fine-tune your clinical skills for preventing and/or minimizing treatment-related adverse events for your patients with hematologic malignancies

Acknowledgment of Commercial Support

This educational activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Genmab US, Inc.; Incyte Corporation; Oncopeptides, Inc.; Pfizer Inc.; Sanofi Genzyme; and Seattle Genetics.

Target Audience: HCPs Who Treat Hematologic Malignancies

This educational activity is directed toward hematologic and medical oncologists involved in the treatment and management of patients with hematologic malignancies, including leukemia, lymphoma, or multiple myeloma. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies are also invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Analyze testing strategies that may inform clinical decision making in the management of hematologic malignancies
  • Apply clinical trial results to multiple lines of care in the management of hematologic malignancies
  • Implement optimal strategies to treat hematologic malignancies
  • Assess disparities in care for patients with hematologic malignancies
  • Develop strategies to proactively prevent, minimize, and manage treatment-related toxicities in patients with leukemia, lymphoma, or multiple myeloma
  • Discuss key emerging data sets regarding the management of patients with hematologic malignancies

Program Co-Chairs

Kenneth C. Anderson
Kenneth C. Anderson, MD
Program Director
Jerome Lipper Multiple Myeloma Center
and LeBow Institute for Myeloma
Dana-Farber Cancer Institute
Institute Physician
Kraft Family Professor of Medicine
Harvard Medical School
Boston, MA
Elias Jabbour
Elias Jabbour, MD
Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX


3 Ways to Register

  1. Online: Click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
  3. Fax: (609) 257-0705 (credit cards only)

Physicians' Education Resource® - MXH20
2 Clarke Drive, Suite 110
Cranbury, NJ 08512

Registration Fees

Physicians $75
Fellows* $50
Nurses, PAs, Other Health Care Professionals $35
Industry** $150

*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.

**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.

For registration assistance, please email, or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to May 11,2020, and a 50% fee on refunds requested on May 12, 2020 through June 11, 2020. No refunds will be made after June 11, 2020. There is no charge for substitution. Substitutions can be applied only to the same conference, and just 2 substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians’ Education Resource®, LLC (PER®), fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

By attending a PER® conference, meeting, or related activity (“Events”), all participants, attendees, exhibitors, sponsors, and guests (“you”) create an agreement between you and PER® regarding the use and distribution of your image, including, but not limited to, your name, voice, and likeness (“Image”). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By